Note: “a” indicates that the number is obtained from a joint sample of two populations (ART and untreated individuals). “-” indicating that the researcher did not conduct testing or did not write down. “Healthy” indicates that they are not infected with HIV; “ART” indicates that HIV patients are receiving antiretroviral therapy; “Untreated” refers to HIV infected individuals who have not received ART treatment. Some references list the duration of ART treatment or HIV infection, but this article does not provide a summary. ART: antiretroviral therapy; ASAP-seq: ATAC with select antigen profile by sequencing; ATAC-seq: Transposase Accessible Chromatin with sequencing; ECCITE-seq: expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing; FIND-seq: Nuclear Acid Detection and Sequencing; FISH: fluorescence in situ hybridization; HICTLs: HIV-infected CD4+ T lymphocytes; HIV: human immunodeficiency virus; PCIP-seq: Pooled CRISPR Inverse PCR sequencing; PheP-seq: Phenotype and Proviral sequencing
The authors declare that there are no conflicts of interest.
Ethical approval
Not applicable.
Consent to participate
Not applicable.
Consent to publication
Not applicable.
Availability of data and materials
Not applicable.
Funding
This work was supported by Shenzhen Committee of Scientific and Technical Innovation grant [JCYJ20180508152244835]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
References
Waterson AP. Acquired immune deficiency syndrome.Br Med J (Clin Res Ed). 1983;286:743–6. [DOI] [PubMed] [PMC]
unaids.org [Internet].Geneva: UNAIDS; [cited 2025 May 12]. Available from: https://unaids.org/en
van der Kuyl AC, Berkhout B. The biased nucleotide composition of the HIV genome: a constant factor in a highly variable virus.Retrovirology. 2012;9:92. [DOI] [PubMed] [PMC]
Douek DC, Brenchley JM, Betts MR, Ambrozak DR, Hill BJ, Okamoto Y, et al. HIV preferentially infects HIV-specific CD4+ T cells.Nature. 2002;417:95–8. [DOI] [PubMed]
Li K, Zhang Q. Eliminating the HIV tissue reservoir: current strategies and challenges.Infect Dis (Lond). 2024;56:165–82. [DOI] [PubMed]
Lee E, Bacchetti P, Milush J, Shao W, Boritz E, Douek D, et al. Memory CD4 + T-Cells Expressing HLA-DR Contribute to HIV Persistence During Prolonged Antiretroviral Therapy.Front Microbiol. 2019;10:2214. [DOI] [PubMed] [PMC]
Fromentin R, Bakeman W, Lawani MB, Khoury G, Hartogensis W, DaFonseca S, et al. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART.PLoS Pathog. 2016;12:e1005761. [DOI] [PubMed] [PMC]
Gougeon M. Apoptosis as an HIV strategy to escape immune attack.Nat Rev Immunol. 2003;3:392–404. [DOI] [PubMed]
Doitsh G, Greene WC. Dissecting How CD4 T Cells Are Lost During HIV Infection.Cell Host Microbe. 2016;19:280–91. [DOI] [PubMed] [PMC]
Dufour C, Gantner P, Fromentin R, Chomont N. The multifaceted nature of HIV latency.J Clin Invest. 2021;131:e151380. [DOI] [PubMed] [PMC]
Siliciano JD, Siliciano RF. In Vivo Dynamics of the Latent Reservoir for HIV-1: New Insights and Implications for Cure.Annu Rev Pathol. 2022;17:271–94. [DOI] [PubMed]
Pasternak AO, Berkhout B. HIV persistence: silence or resistance?Curr Opin Virol. 2023;59:101301. [DOI] [PubMed]
Wang X, Xu H. Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption.Viruses. 2021;13:335. [DOI] [PubMed] [PMC]
Chen J, Zhou T, Zhang Y, Luo S, Chen H, Chen D, et al. The reservoir of latent HIV.Front Cell Infect Microbiol. 2022;12:945956. [DOI] [PubMed] [PMC]
Ortiz AE, Modica A, Fromentin R, Chomont N. Immunological mechanisms involved in the persistence of HIV reservoirs.Virologie (Montrouge). 2022;26:4–16. [DOI] [PubMed]
Mbonye U, Karn J. The cell biology of HIV-1 latency and rebound.Retrovirology. 2024;21:6. [DOI] [PubMed] [PMC]
Freed EO. HIV-1 assembly, release and maturation.Nat Rev Microbiol. 2015;13:484–96. [DOI] [PubMed] [PMC]
Ward AB, Wilson IA. Insights into the trimeric HIV-1 envelope glycoprotein structure.Trends Biochem Sci. 2015;40:101–7. [DOI] [PubMed] [PMC]
Engelman A, Cherepanov P. The structural biology of HIV-1: mechanistic and therapeutic insights.Nat Rev Microbiol. 2012;10:279–90. [DOI] [PubMed] [PMC]
Keller PW, Morrison O, Vassell R, Weiss CD. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.J Virol. 2018;92:e00583–18. [DOI] [PubMed] [PMC]
Costigliola P, Tumietto F, Ricchi E, Chiodo F. Detection of circulating p24 antigen-positive CD4+ cells during HIV infection by flow cytometry.AIDS. 1992;6:1121–5. [DOI] [PubMed]
Gao K, Luo B, Li Y, Xu H, Han Z, Liang C. Detection of intracellular HIV-1 p24 antigen in CD4(+); T cells by flow cytometry and its application for auxiliary diagnosis of HIV-1 infection.Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014;30:426–9. Chinese.
Kux A, Bertram S, Hufert FT, Schmitz H, von Laer D. Antibodies to p24 antigen do not specifically detect HIV-infected lymphocytes in AIDS patients.J Immunol Methods. 1996;191:179–86. [DOI] [PubMed]
Pardons M, Baxter AE, Massanella M, Pagliuzza A, Fromentin R, Dufour C, et al. Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection.PLoS Pathog. 2019;15:e1007619. [DOI] [PubMed] [PMC]
Tessema B, Boldt A, König B, Maier M, Sack U. Flow-Cytometry Intracellular Detection and Quantification of HIV1 p24 Antigen and Immunocheckpoint Molecules in T Cells among HIV/AIDS Patients.HIV AIDS (Auckl). 2022;14:365–79. [DOI] [PubMed] [PMC]
Grau-Expósito J, Serra-Peinado C, Miguel L, Navarro J, Curran A, Burgos J, et al. A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4+ T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients.mBio. 2017;8:e00876–17. [DOI] [PubMed] [PMC]
Baxter AE, Niessl J, Fromentin R, Richard J, Porichis F, Massanella M, et al. Multiparametric characterization of rare HIV-infected cells using an RNA-flow FISH technique.Nat Protoc. 2017;12:2029–49. [DOI] [PubMed] [PMC]
Sannier G, Dubé M, Dufour C, Richard C, Brassard N, Delgado G, et al. Combined single-cell transcriptional, translational, and genomic profiling reveals HIV-1 reservoir diversity.Cell Rep. 2021;36:109643. [DOI] [PubMed]
Collora JA, Liu R, Pinto-Santini D, Ravindra N, Ganoza C, Lama JR, et al. Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones.Immunity. 2022;55:1013–31.e7. [DOI] [PubMed] [PMC]
Clark IC, Mudvari P, Thaploo S, Smith S, Abu-Laban M, Hamouda M, et al. HIV silencing and cell survival signatures in infected T cell reservoirs.Nature. 2023;614:318–25. [DOI] [PubMed] [PMC]
Wu G, Zuck P, Goh SL, Milush JM, Vohra P, Wong JK, et al. Gag p24 Is a Marker of Human Immunodeficiency Virus Expression in Tissues and Correlates With Immune Response.J Infect Dis. 2021;224:1593–8. [DOI] [PubMed] [PMC]
Sun W, Gao C, Hartana CA, Osborn MR, Einkauf KB, Lian X, et al. Phenotypic signatures of immune selection in HIV-1 reservoir cells.Nature. 2023;614:309–17. [DOI] [PubMed] [PMC]
Artesi M, Hahaut V, Cole B, Lambrechts L, Ashrafi F, Marçais A, et al. PCIP-seq: simultaneous sequencing of integrated viral genomes and their insertion sites with long reads.Genome Biol. 2021;22:97. [DOI] [PubMed] [PMC]
Armani-Tourret M, Bone B, Tan TS, Sun W, Bellefroid M, Struyve T, et al. Immune targeting of HIV-1 reservoir cells: a path to elimination strategies and cure.Nat Rev Microbiol. 2024;22:328–44. [DOI] [PubMed] [PMC]
Gantner P, Pagliuzza A, Pardons M, Ramgopal M, Routy J, Fromentin R, et al. Single-cell TCR sequencing reveals phenotypically diverse clonally expanded cells harboring inducible HIV proviruses during ART.Nat Commun. 2020;11:4089. [DOI] [PubMed] [PMC]
Belmonti S, Di Giambenedetto S, Lombardi F. Quantification of Total HIV DNA as a Marker to Measure Viral Reservoir: Methods and Potential Implications for Clinical Practice.Diagnostics (Basel). 2021;12:39. [DOI] [PubMed] [PMC]
Wu VH, Nordin JML, Nguyen S, Joy J, Mampe F, Del Rio Estrada PM, et al. Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4+ T cell reservoir.Nat Immunol. 2023;24:359–70. [DOI] [PubMed] [PMC]